Hannah Petrek

Hannah Petrek, PhD, is currently the Director, Clinical Research Scientist at Immunovant, where they focus on clinical science in global late-stage clinical trials. They previously served as a Lead Clinical Scientist at Genentech, concentrating on oncology and lung immunotherapies. Hannah has a strong background in cancer drug development, having conducted extensive research as a Doctoral Student at UC Davis Health, where they explored microRNA pharmacoepigenetics and RNA-based therapeutics. Their academic journey culminated in a PhD in Biochemistry, Molecular, Cellular, and Developmental Biology from the University of California, Davis.